Stock market week-in-review for 5 large GI companies — July 31-Aug. 4

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 31 to Aug. 4.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $253.07 on July 31
Peaked: $255.22 on July 31
Closed: $242.55 on Aug. 4
Percent change between July 31 and Aug. 4: -4.15 percent

2. Exact Sciences Corp.

Opened: $39.47 on July 31
Peaked: $39.59 on July 31
Closed: $38.69 on Aug. 4
Percent change between July 31 and Aug. 4: -1.97 percent

3. Johnson & Johnson

Opened: $131.84 on July 31
Peaked: $133.91 on Aug. 4
Closed: $133.11 on Aug. 4
Percent change between July 31 and Aug. 4: 0.96 percent

4. Synergy Pharmaceuticals

Opened: $4.06 on July 31
Peaked at open
Closed: $3.72 on Aug. 4
Percent change between July 31 and Aug. 4: -8.37 percent

5. Valeant Pharmaceuticals

Opened: $16.87 on July 31
Peaked at open
Closed: $15.12 on Aug. 4
Percent change between July 31 and Aug. 4: -10.37 percent

More articles on gastroenterology:
Ironwood Pharmaceuticals reports Q2 revenues of $65.1M — 4 insights
GI center to know: Gastro Group & EndoCenter
GI leader to know: Dr. Anthony Albright of Gastro Group & EndoCenter

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.